4 completed, 1 withdrawn. 5 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 4, Withdrawn 1 |
| Phase 2 | 1 | Withdrawn 1 |
Follow Ativan: new trials by email Literature Review of Ativan trials Research Report on Ativan
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Indenoisoquinoline LMP744 in Adults With Relapsed Solid Tumors and Lymphomas LMP744, Ondansetron, Olanzapine - Solid Tumors, Lymphoma | Phase 1 | Completed | National Cancer Institute (NCI) | 36 | 2017-02-27 | 2024-12-10 |
| Catatonia in Nodding Syndrome and Lorazepam Treatment Lorazepam - Catatonia, Nodding Syndrome | Phase 1 | Completed | Makerere University | 16 | 2013-03-01 | 2015-06-03 |
| The Cognitive Effects of Lorazepam in Healthy Older Individuals With TOMM40 Variable-length Polymorphisms lorazepam - Alzheimer's Disease (AD) | Phase 1 | Completed | Mayo Clinic | 57 | 2013-01-01 | 2016-11-10 |
| A Sedation/Cognition/EEG Study Using AZD6280 and Comparator AZD6280, Lorazepam, Placebo - Healthy Volunteer | Phase 1 | Completed | AstraZeneca | 17 | 2008-09-01 | 2009-06-26 |
| GHB Withdrawal Symptoms and Effectiveness of Treatment With Lorazepam Versus Pentobarbital - 1 Lorazepam, Pentobarbital - Substance-Related Disorders | Phase 1 / Phase 2 | Withdrawn | University of California, Los Angeles | 2004-08-01 | 2016-05-12 |
Alzheimer Disease (1) · Catatonia (1) · Lymphoma (1) · Nodding Syndrome (1) · Substance-Related Disorders (1)
AstraZeneca (1) · Makerere University (1) · Mayo Clinic (1) · National Cancer Institute (NCI) (1) · University of California, Los Angeles (1)
United States (3) · Netherlands (1)
Alice P Chen, M.D. (1) · Angelina Kakooza-Mwesige, MMed (1) · Cynthia Stonnington, MD (1) · Dirk M Dhossche, MD, PhD (1) · Karen Miotto, M.D. (1)
K23DA014291 (1)